港股创新药板块持续走低，百济神州跌超10%

Group 1 - The Hong Kong innovative drug sector continues to decline, with companies such as BeiGene and Galmed Pharmaceuticals dropping over 10% [1] - Innovent Biologics experienced a decline of over 7%, while other companies like Zai Lab and CSPC Pharmaceutical Group also saw significant drops [1]